locally

Documents about locally

• ARID1A and/or KDM6A Mutation and CXCL13 Expression#252990ClinicalTrials.gov
• Trying to Find the Correct Length of Treatment With Immune Checkpoint Therapy#353278ClinicalTrials.gov
• Tolinapant and Radiation for Cisplatin-Ineligible, Previously Untreated, Locally Advanced Head and Neck Cancer#807698ClinicalTrials.gov
• Testing Combination Erdafitinib and Enfortumab Vedotin in Metastatic Bladder Cancer After Treatment With Chemotherapy and Immunotherapy#332763ClinicalTrials.gov
• Differentiable manifolds modelled on locally convex spaces#646112Open Research
• MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial#847045ClinicalTrials.gov
• Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Surgery#154631ClinicalTrials.gov
• Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors#865376ClinicalTrials.gov
• Total Neoadjuvant Treatment With or Without Tislelizumab for Locally Advanced Rectal Cancer.#123458ClinicalTrials.gov
• SMART TNT for the Conservative Management of Locally Advanced Rectal Cancer#863357ClinicalTrials.gov
• Impact of Postoperative Radiotherapy Versus PD-1 Inhibitor Maintenance on Survival in Resectable Locally Advanced Oral and Oropharyngeal Squamous Cell Carcinoma#454014ClinicalTrials.gov
• Short-course Radiotherapy Based TNT Combined With PD-1 Inhibitor for Locally Advanced Rectal Cancer#143549ClinicalTrials.gov
• Carboplatin-Paclitaxel-Pembrolizumab in Neoadjuvant Treatment of Locally Advanced Cervical Cancer#283054ClinicalTrials.gov
• Study of Immunotherapy Combined With Chemotherapy in Locally Advanced and Metastatic Pancreatic Cancer#329537ClinicalTrials.gov
• Short-course Radiation Followed by mFOLFOX-6 Plus COMPOUND 2055269 for Locally-advanced Rectal Adenocarcinoma#444862ClinicalTrials.gov
• A Phase 1 Study of BST02 in Treating Locally Advanced Liver Cancer#806681ClinicalTrials.gov
• Zimberelimab Combined With Concurrent Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer#826194ClinicalTrials.gov
• Neoadjuvant Envafolimab in Resectable and Locally Advanced MSI-H/dMMR Rectal Cancer#850967ClinicalTrials.gov
• Optimizing Neoadjuvant Treatment Regimens for Locally Advanced Esophageal Squamous Cell Carcinoma#208457ClinicalTrials.gov
• Dynamic Breast MRI in Assessing Locally Advanced Breast Cancer#857143ClinicalTrials.gov
• Short-course Radiotherapy Combined With Chemotherapy and Pd-1 Inhibitor for Locally Advanced Colon Cancer(TORCH-C)#28319ClinicalTrials.gov
• Hypofractionated Versus Conventional Chemoradiotherapy Followed by Consolidative Immunotherapy in Locally Advanced NSCLC#67888ClinicalTrials.gov
• Immunotherapy in Combination With Chemoradiotherapy in Unresectable Locally Advanced Esophageal Cancer#121336ClinicalTrials.gov
• SCRT Based iTNT vs. LCRT Based TNT for MSS Locally Advanced Rectal Cancer#290981ClinicalTrials.gov
• Safety and Feasibility of Surgery After Conversion Therapy for Locally Advanced and Advanced NSCLC#303752ClinicalTrials.gov
• Real World Study in Locally Advanced or Metastatic NSCLC Patients, Progressed From First-line EGFR-TKI Therapy#353270ClinicalTrials.gov
• Omitting CTV for Locally Advanced NSCLC Responded to Immunotherapy and Chemotherapy#432899ClinicalTrials.gov
• Serplulimab Combined With CAPEOX + Celecoxib as Neoadjuvant Treatment for Locally Advanced Rectal Cancer#448285ClinicalTrials.gov
• Neoadjuvant Long-course Chemoradiotherapy Followed by Immunotherapy for Locally Advanced Mid-low Rectal Cancer#668816ClinicalTrials.gov
• A Series of Neoadjuvant Chemoradiotherapy Combined With Immunotherapy for Locally Advanced Rectal Cancer#836395ClinicalTrials.gov
• The Efficacy of Adjuvant Chemotherapy in Locally Advanced Cervical Cancer#856750ClinicalTrials.gov
• Testing the Addition of Ivonescimab Combined With Standard Chemotherapy Compared to the Usual Chemotherapy and Immunotherapy Treatment for Patients With Advanced Biliary Tract Cancer#481753ClinicalTrials.gov
• Locally compact semi-algebras#490025zbMATH Open
• Locally Served DNS Zones#501442IETF RFCs
• PACCELIO - FDG-PET Based Small Volume Accelerated Immuno Chemoradiotherapy in Locally Advanced NSCLC#329511ClinicalTrials.gov
• Circulating Tumor DNA-guided Neoadjuvant Treatment Strategy for Locally Advanced Rectal Cancer#390901ClinicalTrials.gov
• Toripalimab Maintenance for Locally Advanced Head and Neck Squamous Cell Carcinoma#411384ClinicalTrials.gov
• Neoadjuvant Short-course Radiotherapy Followed by the Combination of Immunotherapy and Chemotherapy in Locally Advanced Rectal Cancer#651255ClinicalTrials.gov
• Different Patterns of Target Delineation in SBRT for Locally Advanced Pancreatic Cancer#859778ClinicalTrials.gov
• A Study of OMP-313M32 in Subjects With Locally Advanced or Metastatic Solid Tumors#866714ClinicalTrials.gov
• Immune Checkpoint Inhibitors With or Without Propranolol Hydrochloride In Patients With Urothelial Carcinoma#866677ClinicalTrials.gov
• A Clinical Study of QL1706 Combined With Chemotherapy as Neoadjuvant Therapy for High-Risk Locally Advanced Cervical Cancer#363625ClinicalTrials.gov
• Tirelizumab Combined With Chemotherapy in the Treatment of HER-2 Negative Locally Advanced Gastric Cancer#390931ClinicalTrials.gov
• Solution of monotone complementarity problems with locally Lipschitzian functions#429988Dipòsit Digital de Documents de la UAB
• Stereotactic Body Radiation Therapy (SABR) for Definitive Treatment of Locally Advanced Cervical Cancer#847314ClinicalTrials.gov
• CapeOX Combined With Bevacizumab Plus Anti-PD1 Antibody as Neoadjuvant Therapy for Locally Recurrent Colorectal Cancer#857517ClinicalTrials.gov
• Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma#184850ClinicalTrials.gov
• Locally covariant quantum field theory#498699INSPIRE-HEP
• When Structural Principles Hold Merely Locally#740159PhilArchive
• Preoperative Short-course Radiation Followed by Envafolimab Plus CAPEOX for MSS Locally Advanced Rectal Adenocarcinoma (PRECAM)#125816ClinicalTrials.gov